United States · 
Who invested in Newleos Therapeutics?
Newleos Therapeutics's investors include Goldman Sachs, DCVC, Novo Holdings and Longwood Fund.
United States · Series A startup
Who invested in Newleos Therapeutics
Funding summaryUpdated 26 Oct 2026
$94Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $94MFeb 2025
- Investors
- 4
The rounds
- Feb 2025Series A$94M
Source recordedSEC filing: $93M sold, first sale Feb 2025
Founders and team
From Newleos Therapeutics's own website: 8 on the team.
- Timothy NoyesChief Executive Officer
- Adam SimmonsVice President, Clinical Operations & Development
- Brian SheaVice President, Head of Legal
- Kyle AudiVice President, Finance
- Sondra SmyrniosSenior Vice President, Clinical and Technical Operations
- John McCabeChief Financial Officer
- Rohan PalekarChairman
- Goldman Sachs AlternativesTeam
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Newleos Therapeutics
How much has Newleos Therapeutics raised?
Newleos Therapeutics has raised $94M across 1 round since 2025.
When did Newleos Therapeutics last raise?
Newleos Therapeutics's most recent round was a Series A of $94M in Feb 2025.
What was Newleos Therapeutics's biggest round?
Its most recent round, $94M in Feb 2025, is also its largest on record.
Who backed Newleos Therapeutics first?
Newleos Therapeutics's first round on record, in Feb 2025, was backed by Goldman Sachs, DCVC and Novo Holdings and 1 others.
What stage is Newleos Therapeutics at?
Newleos Therapeutics's latest named round is a Series A, in Feb 2025.
Where is Newleos Therapeutics based?
Newleos Therapeutics is based in the United States.
Companies like Newleos Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.